Progression-Free Survival and Clinical Outcomes with Long-Term Use of Telotristat Ethyl in US Clinical Practice

被引：0
|
作者：
Metz, D. C. [1 ]
Liu, E. [2 ]
Joish, V. N. [3 ]
Huynh, L. [4 ]
Cheng, M. [4 ]
Kunzweiler, C. [4 ]
Duh, M. S. [4 ]
Giacalone, S. [3 ]
Lapuerta, P. [3 ]
Morse, M. A. [5 ]
机构：
[1] Neuroendocrine Tumor Ctr Penn Med, Philadelphia, PA USA
[2] Rocky Mt Canc Ctr, Neuroendocrine Inst, Denver, CO USA
[3] Lexicon Pharmaceut Inc, The Woodlands, TX USA
[4] Anal Grp, Boston, MA USA
[5] Duke Univ, Sch Med, Duke Canc Inst, Durham, NC USA
来源：
NEUROENDOCRINOLOGY | 2020年 / 110卷
关键词：
neuroendocrine tumor; carcinoid syndrome; telotristat ethyl; serotonin; tumor growth; progression-free survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H21
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [41] Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
    Pawlyn, Charlotte
    Schjesvold, Fredrik H.
    Cairns, David A.
    Wei, L. J.
    Davies, Faith
    Nadeem, Omar
    Abdulhaq, Haifaa
    Mateos, Maria-Victoria
    Laubach, Jacob
    Weisel, Katja
    Ludwig, Heinz
    Rajkumar, S. Vincent
    Sonneveld, Pieter
    Jackson, Graham
    Morgan, Gareth
    Richardson, Paul G.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [42] Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials
    Denne, J. S.
    Stone, A. M.
    Bailey-Iacona, R.
    Chen, T. -T.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (05) : 951 - 970
  • [43] Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas
    Mark A. Davison
    Daniel T. Lilly
    Arpan A. Patel
    Ahmed Kashkoush
    Xiaoying Chen
    Wei Wei
    Edward C. Benzel
    Richard A. Prayson
    Samuel Chao
    Lilyana Angelov
    Journal of Neuro-Oncology, 2024, 167 : 437 - 446
  • [44] Long-term Outcomes of Infliximab Use for Pediatric Crohn Disease: A Canadian Multicenter Clinical Practice Experience
    deBruyn, Jennifer C.
    Jacobson, Kevan
    El-Matary, Wael
    Carroll, Matthew
    Wine, Eytan
    Wrobel, Iwona
    Van Woudenberg, Mariel
    Huynh, Hien Q.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (02): : 268 - 273
  • [45] Long-Term Survival of Methotrexate in Giant Cell Arteritis Patients in Clinical Practice
    Freites Nunez, Dalifer
    Rosales, Zulema
    Arietti, Lucia
    Leon, Leticia
    Morado, Inmaculada
    Fernandez-Gutierrez, Benjamin
    Rodriguez-Rodriguez, Luis
    Jover, Juan A.
    Abasolo, Lydia
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review
    Zhang, Di
    Huang, Jiaqi
    Sun, Yulan
    Guo, Qisen
    ONCOTARGETS AND THERAPY, 2019, 12 : 3635 - 3644
  • [47] Long term use of ustekinumab in clinical practice
    Garcia-Lario, Andrea
    Ramio Montero, Elvira
    Segui Solanes, Carlos
    Modamio, Pilar
    Pons Busom, Montserrat
    Marino, Eduardo L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 306 - 306
  • [48] Pleural mesothelioma: Long-term progression-free survival with Tumor Treating Fields (TTFields) therapy case reports
    Ceresoli, Giovanni Luca
    Mannarino, Laura
    Paracchini, Lara
    Grosso, Federica
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2025, 17
  • [49] LONG-TERM PROGRESSION-FREE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME TREATED WITH A COMBINATION OF TARGETED AGENTS: A CASE REPORT
    Burzynski, Stanislaw
    Burzynski, Gregory
    NEURO-ONCOLOGY, 2014, 16
  • [50] Metformin Use and Long-term Clinical Outcomes in Kidney Transplant Recipients
    Kwon, Soie
    Kim, Yong Chul
    Kwon, Hyunwook
    Cho, Jang-Hee
    Kim, Chan-Duck
    Son, Hyung-Eun
    Jeong, Jong-Cheol
    Jung, In Mok
    Yoo, Kyung Don
    Kim, Yeonjin
    Lee, Woojoo
    Lee, Jong Soo
    Lee, Hajeong
    Lim, Chun Soo
    Kim, Yon Su
    Kim, Young Hoon
    Lee, Jung Pyo
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 82 (03) : 290 - 299.e1
12345